Literature DB >> 17593519

Lipoprotein glomerulopathy-like disease in a patient with type III hyperlipoproteinemia due to apolipoprotein E2 (Arg158 Cys)/3 heterozygosity.

Miho Karube1, Kimimasa Nakabayashi2, Yasunori Fujioka3, Ken Yoshihara1, Akira Yamada1, Akira Matsunaga4, Takao Saito5.   

Abstract

A 77-year-old woman developed nephrotic syndrome associated with type III hyperlipoproteinemia (III HLP) and increased apolipoprotein E (apo E). Apo E analysis disclosed E2/E3 heterozygosity in phenotypic and genotypic expressions, without any other mutations. A renal biopsy showed intraluminal and subendothelial thrombus-like deposits in the dilated capillary loops of the glomerulus that stained positive for lipids and apo E. Electron microscopy revealed tiny granular particles in the capillary lumina, as well as between the glomerular basement membrane and the endothelial cells. It was therefore concluded that III HLP associated with apo E2/E3 heterozygosity could induce lipoprotein glomerulopathy-like disease and nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593519     DOI: 10.1007/s10157-007-0469-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  21 in total

Review 1.  Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Authors:  Takao Saito; Akira Matsunaga; Shinichi Oikawa
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Glomerular lipid deposition and proteinuria in a patient with familial dysbetalipoproteinaemia.

Authors:  K R Balson; J F Niall; J D Best
Journal:  J Intern Med       Date:  1996-09       Impact factor: 8.989

4.  Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.

Authors:  M Sakatsume; M Kadomura; I Sakata; N Imai; D Kondo; Y Osawa; H Shimada; M Ueno; T Miida; S Nishi; M Arakawa; F Gejyo
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

5.  Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.

Authors:  K Suzaki; S Kobori; S Ueno; M Uehara; T Kayashima; H Takeda; S Fukuda; K Takahashi; N Nakamura; H Uzawa
Journal:  Atherosclerosis       Date:  1990-01       Impact factor: 5.162

6.  Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli.

Authors:  J M Amatruda; S Margolis; G M Hutchins
Journal:  Arch Pathol       Date:  1974-07

Review 7.  Apolipoprotein E polymorphism in health and disease.

Authors:  G Utermann
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

Review 8.  A case of lipoprotein glomerulopathy successfully treated with probucol.

Authors:  M Amenomori; M Haneda; J Morikawa; I Nishigaki; S Maeda; H Hidaka; R Kikkawa; Y Shigeta
Journal:  Nephron       Date:  1994       Impact factor: 2.847

9.  Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia.

Authors:  T Saito; H Sato; K Kudo; S Oikawa; T Shibata; Y Hara; K Yoshinaga; H Sakaguchi
Journal:  Am J Kidney Dis       Date:  1989-02       Impact factor: 8.860

10.  Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.

Authors:  G Feussner; A Wagner; B Kohl; R Ziegler
Journal:  Clin Investig       Date:  1993-05
View more
  3 in total

1.  Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Hui-Ling Xu
Journal:  Mol Biol Rep       Date:  2012-07-04       Impact factor: 2.316

Review 2.  An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.

Authors:  Meng-Shi Li; Yang Li; Yang Liu; Xu-Jie Zhou; Hong Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-06

Review 3.  Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.

Authors:  Akira Matsunaga; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2014-02-26       Impact factor: 2.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.